Activation of ephrinB–EphB receptor signalling in rat spinal cord contributes to maintenance of diabetic neuropathic pain

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Pain

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ejp.922PMID 27461472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p38α (MAPK14) critically regulates the immunological response and the production of specific cytokines and chemokines in astrocytes

  2014influential reference
• Decrease in neuroimmune activation by HSV-mediated gene transfer of TNFα soluble receptor alleviates pain in rats with diabetic neuropathy.

  2014cited by this paper
• WNT signaling underlies the pathogenesis of neuropathic pain in rodents.

  2013cited by this paper
• A randomized controlled pilot study of a cognitive-behavioral therapy approach for painful diabetic peripheral neuropathy.

  2013cited by this paper
• EphrinB‐EphB receptor signaling contributes to bone cancer pain via Toll‐like receptor and proinflammatory cytokines in rat spinal cord

  2013cited by this paper
• Mechanisms of axonal dysfunction in diabetic and uraemic neuropathies.

  2013cited by this paper
• A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.

  2012cited by this paper
• Neuron–astrocyte signaling network in spinal cord dorsal horn mediates painful neuropathy of type 2 diabetes

  2012cited by this paper
• Looking forward to EphB signaling in synapses.

  2012cited by this paper
• EphBs: an integral link between synaptic function and synaptopathies.

  2012cited by this paper
• Eph/Ephrin signaling in injury and inflammation.

  2012cited by this paper
• An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings.

  2012cited by this paper
• Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain

  2012cited by this paper
• Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents.

  2011cited by this paper
• Astrocyte reactivity to unconjugated bilirubin requires TNF‐α and IL‐1β receptor signaling pathways

  2011cited by this paper
• Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway.

  2011cited by this paper
• Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes.

  2011influential reference
• A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost.

  2011cited by this paper
• Spinal injection of TNF‐α‐activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein‐1

  2010cited by this paper
• Analysis of the antinociceptive interactions in two-drug combinations of gabapentin, oxcarbazepine and amitriptyline in streptozotocin-induced diabetic mice.

  2010cited by this paper
• Diabetic Neuropathy

  2010cited by this paper
• Spinal Matrix Metalloproteinase-9 Contributes to Physical Dependence on Morphine in Mice

  2010influential reference
• Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?

  2010cited by this paper
• Comparative effectiveness

  2009cited by this paper
• EphB receptor signaling in mouse spinal cord contributes to physical dependence on morphine

  2009cited by this paper
• Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes

  2009cited by this paper
• Bidirectional modulation of synaptic functions by Eph/ephrin signaling

  2009cited by this paper
• Diabetes and the peripheral nerve.

  2009influential reference
• Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain

  2009cited by this paper
• Upregulation and redistribution of ephrinB and EphB receptor in dorsal root ganglion and spinal dorsal horn neurons after peripheral nerve injury and dorsal rhizotomy

  2008cited by this paper
• The role of inflammatory cytokines in diabetes and its complications.

  2008cited by this paper
• EphrinB‐EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats

  2008cited by this paper
• Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice

  2008cited by this paper
• Diabetic neuropathy: mechanisms to management.

  2008cited by this paper
• Alterations in mRNA Expression of Myelin Proteins in the Sciatic Nerves and Brains of Streptozotocin-induced Diabetic Rats

  2007cited by this paper
• EphB1 null mice exhibit neuronal loss in substantia nigra pars reticulata and spontaneous locomotor hyperactivity

  2007cited by this paper
• Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications

  2007influential reference
• Cell-cell signaling via Eph receptors and ephrins.

  2007cited by this paper
• Differential expression of cytokines in painful and painless neuropathies

  2007cited by this paper
• Inflammation and metabolic disorders

  2006cited by this paper
• Diabetic neuropathy is associated with activation of the TNF‐α system in subjects with type 1 diabetes mellitus

  2005influential reference
• Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation

  2005cited by this paper
• The pathobiology of diabetic complications: a unifying mechanism.

  2005influential reference
• Developmental cell biology: Eph receptor signalling casts a wide net on cell behaviour

  2005cited by this paper
• Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.

  2004cited by this paper
• New Insights into the Mechanisms of Diabetic Neuropathy

  2004influential reference
• Ephrin-B2 and EphB2 Regulation of Astrocyte-Meningeal Fibroblast Interactions in Response to Spinal Cord Lesions in Adult Rats

  2003cited by this paper
• Eph signaling: a structural view.

  2003cited by this paper
• Control of skeletal patterning by ephrinB1-EphB interactions.

  2003cited by this paper
• Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats.

  2002cited by this paper
• Mechanical and thermal hyperalgesia and ectopic neuronal discharge after chronic compression of dorsal root ganglia.

  1999cited by this paper
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

  1988cited by this paper

• Spinal neuron-glial crosstalk and ion channel dysregulation in diabetic neuropathic pain

  2025cites this paper
• EphB1-NR2B receptor signaling in glutamatergic neurons of the ventroposteromedial thalamic nucleus regulates emergence from anesthesia

  2025cites this paper
• Astrogliopathology: A core pathogenic factor in diabetic neuropathic pain

  2025cites this paper
• Admixture Mapping of Chronic Kidney Disease and Risk Factors in Hispanic/Latino Individuals From Central America Country of Origin

  2024cites this paper
• Angiotensin II Type 1 receptor blockade attenuates the neuropathological changes in the spinal cords of diabetic rats with modulation of nuclear factor erythroid 2-related factor 2/ heme oxygenase 1 system.

  2024cites this paper
• Diabetic Neuropathic Pain: Directions for Exploring Treatments

  2024cites this paper
• EphB1 causes retinal damage through inflammatory pathways in the retina and retinal Müller cells

  2024cites this paper
• Mechanisms and Therapeutic Prospects of Microglia-Astrocyte Interactions in Neuropathic Pain Following Spinal Cord Injury

  2024cites this paper
• TRPV1: a novel target for the therapy of diabetes and diabetic complications.

  2024cites this paper
• Disentangling the enigmatic role of ephrin signaling in chronic pain: Moving towards future anti-pain therapeutics.

  2023cites this paper
• The Eph/ephrin system symphony of gut inflammation.

  2023cites this paper
• Answering Big Questions in Pain Medicine

  2023cites this paper
• Ephrin B/EphB in neuropathic pain: Role and molecular mechanisms

  2023cites this paper
• Suppression of neuronal apoptosis and glial activation with modulation of Nrf2/HO-1 and NF-kB signaling by curcumin in streptozotocin-induced diabetic spinal cord central neuropathy

  2023cites this paper
• Admixture mapping screening of CKD traits and risk factors in U.S. Hispanic/Latino individuals from Central America country-of-origin

  2022cites this paper
• The Involvement of Caspases in Neuroinflammation and Neuronal Apoptosis in Chronic Pain and Potential Therapeutic Targets

  2022cites this paper
• Axon Guidance Molecules and Pain

  2022influential citation
• Progesterone modulates the expression of spinal ephrin-B2 after peripheral nerve injury: New insights into progesterone mechanisms.

  2022cites this paper
• Astrocytes in rare neurological conditions: Morphological and functional considerations

  2021cites this paper
• Activation of spinal ephrin‐B3/EphBs signaling induces hyperalgesia through a PLP‐mediated mechanism

  2021cites this paper
• Fluorocitrate and neurotropin confer analgesic effects on neuropathic pain in diabetic rats via inhibition of astrocyte activation in the periaqueductal gray.

  2021cites this paper
• Role of Matrix Metalloproteinases in Myelin Abnormalities and Mechanical Allodynia in Rodents with Diabetic Neuropathy

  2021cites this paper
• Conditional Deletion of EphA4 on Cx3cr1-Expressing Microglia Fails to Influence Histopathological Outcome and Blood Brain Barrier Disruption Following Brain Injury

  2021cites this paper
• Blockade of Erythropoietin-Producing Human Hepatocellular Carcinoma Receptor B1 in Spinal Dorsal Horn Alleviates Visceral Pain in Rats

  2021cites this paper
• Ephrin‐B2 signaling in the spinal cord as a player in post‐inflammatory and stress‐induced visceral hypersensitivity

  2020cites this paper
• Peripheral EphrinB1/EphB1 signalling attenuates muscle hyperalgesia in MPS patients and a rat model of taut band-associated persistent muscle pain

  2020cites this paper
• Activation of EphB receptors contributes to primary sensory neuron excitability by facilitating Ca2+ influx directly or through Src kinase-mediated NMDA receptor phosphorylation.

  2020cites this paper
• Systematic Administration of B Vitamins Alleviates Diabetic Pain and Inhibits Associated Expression of P2X3 and TRPV1 in Dorsal Root Ganglion Neurons and Proinflammatory Cytokines in Spinal Cord in Rats

  2020cites this paper
• Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway

  2020cites this paper
• Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin‐resistant mice

  2019cites this paper
• Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice.

  2019cites this paper
• Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain

  2018cites this paper
• Emerging drugs for diabetic peripheral neuropathy and neuropathic pain

  2016cites this paper